Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Regeneron Pharmaceuticals
(NQ:
REGN
)
985.02
+4.45 (+0.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Regeneron Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Value Stocks Outshine Growth Amidst Rising Treasury Yields: Key Sectors and Stocks Analyzed
August 21, 2023
The Vanguard Value Index Fund ETF (ARCA: VTV) has beaten the Vanguard Growth Index Fund ETF (ARCA: VUG) by 5% during the past month. The momentum shift comes as investors recalibrate their strategies...
Via
Benzinga
Topics
ETFs
Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner
August 21, 2023
Biotech stocks are in a bear market since the IBB hit $177.37 in 2021 and is down 7.84% over five years.
Via
Talk Markets
FDA Approves Regeneron's Drug For Ultra Rare Immune Disorder
August 21, 2023
The FDA approved Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) Veopoz (pozelimab-bbfg) for adult and pediatric patients one year of age and older with CHAPLE disease, known as CD55-deficient
Via
Benzinga
Exposures
Product Safety
Why This Regeneron Approval 'Could Not Come Soon Enough' As Novartis Looms
August 21, 2023
The FDA signed off on Regeneron's high-dose Eylea about two months earlier than expected.
Via
Investor's Business Daily
Exposures
Product Safety
18 Analysts Have This to Say About Regeneron Pharmaceuticals
August 16, 2023
Via
Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $5,400 Today
August 15, 2023
Via
Benzinga
This Is What Whales Are Betting On Regeneron Pharmaceuticals
August 14, 2023
Via
Benzinga
FDA Approves Regeneron Pharmaceuticals' Higher Dose Of Eylea For Age-Related Blindness
August 21, 2023
The FDA approved Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) approved Eylea HD (aflibercept) Injection 8 mg for wet age-related macular degeneration (wAMD), diabetic macular edema (DME),
Via
Benzinga
Exposures
Product Safety
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
August 21, 2023
The biotech's focus on innovation could be a boon for shareholders.
Via
The Motley Fool
Top Biotech Roivant, Formed By Vivek Ramaswamy, Reports Steep Losses, Light Sales
August 14, 2023
The company is working on a treatment for stomach diseases ulcerative colitis and Crohn's disease.
Via
Investor's Business Daily
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
August 11, 2023
Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be...
Via
Benzinga
Why the quality investor may take a look at NASDAQ:REGN.
August 11, 2023
REGENERON PHARMACEUTICALS (NASDAQ:REGN) may be suited for quality investing, we'll explore why in this article.
Via
Chartmill
This Is What Whales Are Betting On Regeneron Pharmaceuticals
August 10, 2023
Via
Benzinga
(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest
August 04, 2023
Via
Benzinga
Regeneron Surmounts Its 200-Day Line On A Handy Second-Quarter Beat
August 03, 2023
Shares have been trapped below their 200-day moving average since late June.
Via
Investor's Business Daily
The 7 Best Value Stocks to Buy in August
August 10, 2023
Stop chasing the hot flavors of the week and instead be friendly to your wallet with these ideas for best value stocks to buy.
Via
InvestorPlace
Regeneron's Aflibercept 8mg Shows Sustained Vision Gains At Two Years
August 10, 2023
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced two-year (96 weeks) topline data from the pivotal PULSAR trial investigating aflibercept 8 mg in patients with wet age-related
Via
Benzinga
3 Top Biotech Stocks Defying the Bear Market
August 10, 2023
Biotech is still booming, if you pick the right biotech stocks.
Via
The Motley Fool
Health Care Company Regeneron Pharmaceuticals Announces Acquisition of Decibel Therapeutics
August 09, 2023
Via
Benzinga
Decibel Therapeutics (DBTX) Stock Skyrockets 71% on Regeneron Deal
August 09, 2023
Decibel Therapeutics (DBTX) stock is soaring higher on Wednesday after signing a deal with Regeneron Pharmaceuticals (REGN).
Via
InvestorPlace
Decibel Therapeutics Stock Soars on Acquisition Deal - The Details
August 09, 2023
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) has agreed to acquire Decibel Therapeutics Inc (NASDAQ: DBTX) at $4.00 per share with an additional contingent value right of up to $3.50 per share in cash...
Via
Benzinga
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Regeneron Pharmaceuticals Earnings Preview
August 02, 2023
Via
Benzinga
3 AI Stocks You’ll Regret Not Buying Soon
August 08, 2023
AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in.
Via
InvestorPlace
2 Top Stocks to Buy in August and Hold Forever
August 06, 2023
These companies won't disappoint long-term investors.
Via
The Motley Fool
Market Rally Under Pressure As Yields Soar; Amazon, ELF, Caterpillar Are Earnings Winners: Weekly Review
August 04, 2023
Amazon, ELF and CAT were earnings winners, but there were big losers too.
Via
Investor's Business Daily
Clorox, Boot Barn, Herbalife, Upwork And Other Big Stocks Moving Higher On Thursday
August 03, 2023
U.S. stocks traded lower, with the Dow Jones falling around 100 points on Thursday. Here are some big stocks recording gains in today’s session. Traeger, Inc. (NYSE: COOK) shares jumped 43.2% to $5.90...
Via
Benzinga
Why Is Regeneron Pharmaceuticals Moving Higher Today?
August 03, 2023
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) earned second-quarter adjusted EPS of $10.24, up 5% Y/Y, beating the $9.92 Stre
Via
Benzinga
US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month
August 03, 2023
Stocks appear to be entrenched in an August swoon and it remains to be seen if big tech earnings provide a boost.
Via
Benzinga
Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points
August 01, 2023
Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.